Tables

TABLE 1 LIST OF CANCER IMMUNOTHERAPY DRUGS APPROVED (2016-APRIL 2019) 24
TABLE 2 GLOBAL IMMUNOTHERAPY DRUGS MARKET REVENUE BY DRUG TYPE' 2018-2025 ($BILLION) 35
TABLE 3 GLOBAL IMMUNOTHERAPY DRUGS MARKET REVENUE BY TREATMENT AREA' 2018-2025 ($BILLION) 44
TABLE 4 GLOBAL IMMUNOTHERAPY DRUGS MARKET REVENUE BY REGIONS' 2018-2025 ($BILLION) 51
TABLE 5 GLOBAL IMMUNOTHERAPY DRUGS MARKET BY VENDOR RANKING' 2018 60
TABLE 6 OTHER PROMINENT VENDORS OF IMMUNOTHERAPY DRUGS MARKET 60
TABLE 7 ABBVIE INC.: OFFERINGS 61
TABLE 8 ABBVIE INC.: RECENT DEVELOPMENTS 61
TABLE 9 AMGEN INC.: OFFERINGS 66
TABLE 10 AMGEN INC.: RECENT DEVELOPMENTS 66
TABLE 11 F. HOFFMANN-LA ROCHE LTD.: PRODUCT OFFERINGS 71
TABLE 12 F. HOFFMANN-LA ROCHE LTD.: RECENT DEVELOPMENTS 71
TABLE 13 BRISTOL-MYERS SQUIBB: OFFERINGS 75
TABLE 14 BRISTOL-MYERS SQUIBB: RECENT DEVELOPMENT 75
TABLE 15 JOHNSON & JOHNSON: PRODUCT OFFERINGS 81
TABLE 16 JOHNSON & JOHNSON: RECENT DEVELOPMENTS 81
TABLE 17 MERCK & CO.' INC.: PRODUCT OFFERINGS 88
TABLE 18 MERCK & CO.' INC.: RECENT DEVELOPMENTS 89
TABLE 19 NOVARTIS AG: SNAPSHOT 95
TABLE 20 NOVARTIS AG: RECENT DEVELOPMENTS 95
TABLE 21 GLAXOSMITHKLINE PLC: SNAPSHOT 98
TABLE 22 GLAXOSMITHKLINE PLC: RECENT DEVELOPMENTS 98
TABLE 23 ASTRAZENECA PLC: SNAPSHOT 100
TABLE 24 ASTRAZENECA PLC: RECENT DEVELOPMENTS 100
TABLE 25 ELI LILLY AND COMPANY LTD: SNAPSHOT 101
TABLE 26 ELI LILLY AND COMPANY LTD: RECENT DEVELOPMENTS 101

?

LIST OF FIGURE

Charts

CHART 1 GLOBAL PRESCRIPTION DRUG SALES' 2018-2025 ($BILLION) 10
CHART 2 GLOBAL OVER-THE-COUNTER DRUG MARKET REVENUE' 2018-2025' $BILLION 10
CHART 3 GLOBAL PHARMA SALES' BIOLOGICS V/S NON-BIOLOGICS (%) 11
CHART 4 GLOBAL PHARMACEUTICAL SALES BY REGION' 2018 12
CHART 5 GLOBAL PHARMACEUTICAL R&D SPENDING (2010-2017) 13
CHART 6 PHARMACEUTICAL DRUGS BY SALES' 2018 ($BILLION) 14
CHART 7 RESEARCH METHODOLOGY OF GLOBAL IMMUNOTHERAPY DRUGS MARKET 17
CHART 8 GLOBAL IMMUNOTHERAPY DRUGS MARKET REVENUE' 2018-2025 ($BILLION) 20
CHART 9 SEGMENTATION OF GLOBAL IMMUNOTHERAPY DRUGS MARKET 26
CHART 10 PEST ANALYSIS OF GLOBAL IMMUNOTHERAPY DRUGS MARKET 27
CHART 11 PORTER 5 FORCES ON GLOBAL IMMUNOTHERAPY DRUGS MARKET 28
CHART 12 MARKET DYNAMICS - DRO ANALYSIS 29
CHART 13 DRO - IMPACT ANALYSIS OF GLOBAL IMMUNOTHERAPY DRUGS MARKET 32
CHART 14 KEY STAKEHOLDERS 33
CHART 15 GLOBAL IMMUNOTHERAPY DRUGS MARKET BY DRUG TYPE SEGMENTATION' 2018 AND 2025 ($BILLION) 35
CHART 16 GLOBAL MONOCLONAL ANTIBODY MARKET REVENUE' 2018-2025 ($BILLION) 37
CHART 17 GLOBAL VACCINE MARKET REVENUE' 2018-2025 ($BILLION) 38
CHART 18 GLOBAL NON-SPECIFIC IMMUNOTHERAPY MARKET REVENUE' 2018-2025 ($BILLION) 39
CHART 19 GLOBAL ADAPTIVE CELL THERAPY MARKET REVENUE' 2018-2025 ($BILLION) 41
CHART 20 GLOBAL OTHERS MARKET REVENUE' 2018-2025 ($BILLION) 42
CHART 21 GLOBAL IMMUNOTHERAPY DRUGS MARKET BY TREATMENT AREA SEGMENTATION' 2018 (%) 43
CHART 22 GLOBAL IMMUNOTHERAPY DRUGS MARKET BY TREATMENT AREA SEGMENTATION' 2025 (%) 44
CHART 23 GLOBAL CANCER MARKET REVENUE' 2018-2025 ($BILLION) 45
CHART 24 GLOBAL INFLAMMATORY AND AUTOIMMUNE DISEASE MARKET REVENUE' 2018-2025 ($BILLION) 46
CHART 25 GLOBAL INFECTIOUS DISEASE MARKET REVENUE' 2018-2025 ($BILLION) 48
CHART 26 GLOBAL OTHERS MARKET REVENUE' 2018-2025 ($BILLION) 48
CHART 27 GLOBAL IMMUNOTHERAPY DRUGS MARKET BY GEOGRAPHICAL SEGMENTATION' 2018 (%) 50
CHART 28 GLOBAL IMMUNOTHERAPY DRUGS MARKET BY GEOGRAPHICAL SEGMENTATION' 2025 (%) 51
CHART 29 IMMUNOTHERAPY DRUGS MARKET REVENUE IN NORTH AMERICA' 2018-2025 ($BILLION) 52
CHART 30 IMMUNOTHERAPY DRUGS MARKET REVENUE IN EUROPE' 2018-2025 ($BILLION) 54
CHART 31 IMMUNOTHERAPY DRUGS MARKET REVENUE IN ASIA PACIFIC' 2018-2025 ($BILLION) 55
CHART 32 IMMUNOTHERAPY DRUGS MARKET REVENUE IN REST OF THE WORLD' 2018-2025 ($BILLION) 57
CHART 33 ABBVIE INC.: OVERVIEW SNAPSHOT 62
CHART 34 ABBVIE INC.: GEOGRAPHIC REVENUE 63
CHART 35 ABBVIE INC.: SWOT ANALYSIS 65
CHART 36 AMGEN INC.: OVERVIEW SNAPSHOT 67
CHART 37 AMGEN INC.: GEOGRAPHIC REVENUE 68
CHART 38 AMGEN INC.: SWOT ANALYSIS 69
CHART 39 F. HOFFMANN-LA ROCHE LTD.: OVERVIEW SNAPSHOT 72
CHART 40 F. HOFFMANN-LA ROCHE LTD.: BUSINESS UNITS 72
CHART 41 F. HOFFMANN-LA ROCHE LTD.: GEOGRAPHIC REVENUE 73
CHART 42 F. HOFFMANN-LA ROCHE LTD.: SWOT ANALYSIS 74
CHART 43 BRISTOL-MYERS SQUIBB: OVERVIEW SNAPSHOT 78
CHART 44 BRISTOL-MYERS SQUIBB: GEOGRAPHIC REVENUE 78
CHART 45 BRISTOL-MYERS SQUIBB: SWOT ANALYSIS 79
CHART 46 JOHNSON & JOHNSON: OVERVIEW SNAPSHOT 84
CHART 47 JOHNSON & JOHNSON: BUSINESS UNITS 84
CHART 48 JOHNSON & JOHNSON: GEOGRAPHICAL REVENUE 85
CHART 49 JOHNSON & JOHNSON: SWOT ANALYSIS 87
CHART 50 MERCK & CO.' INC.: OVERVIEW SNAPSHOT 90
CHART 51 MERCK & CO.' INC.: BUSINESS UNITS 91
CHART 52 MERCK & CO.' INC.: GEOGRAPHICAL REVENUE 92
CHART 53 MERCK & CO.' INC.: SWOT ANALYSIS 94